Research ArticleArticle
Open Access
Rapid Improvement in the Signs and Symptoms of Rheumatoid Arthritis Following Certolizumab Pegol Treatment Predicts Better Longterm Outcomes: Post-hoc Analysis of a Randomized Controlled Trial
Edward C. Keystone, Jeffrey R. Curtis, Roy M. Fleischmann, Daniel E. Furst, Dinesh Khanna, Josef S. Smolen, Philip J. Mease, Michael H. Schiff, Geoffroy Coteur, Owen Davies and Bernard Combe
The Journal of Rheumatology March 2011, jrheum.100935; DOI: https://doi.org/10.3899/jrheum.100935
Edward C. Keystone
Jeffrey R. Curtis
Roy M. Fleischmann
Daniel E. Furst
Dinesh Khanna
Josef S. Smolen
Philip J. Mease
Michael H. Schiff
Geoffroy Coteur
Owen Davies
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Rapid Improvement in the Signs and Symptoms of Rheumatoid Arthritis Following Certolizumab Pegol Treatment Predicts Better Longterm Outcomes: Post-hoc Analysis of a Randomized Controlled Trial
Edward C. Keystone, Jeffrey R. Curtis, Roy M. Fleischmann, Daniel E. Furst, Dinesh Khanna, Josef S. Smolen, Philip J. Mease, Michael H. Schiff, Geoffroy Coteur, Owen Davies, Bernard Combe
The Journal of Rheumatology Mar 2011, jrheum.100935; DOI: 10.3899/jrheum.100935
Rapid Improvement in the Signs and Symptoms of Rheumatoid Arthritis Following Certolizumab Pegol Treatment Predicts Better Longterm Outcomes: Post-hoc Analysis of a Randomized Controlled Trial
Edward C. Keystone, Jeffrey R. Curtis, Roy M. Fleischmann, Daniel E. Furst, Dinesh Khanna, Josef S. Smolen, Philip J. Mease, Michael H. Schiff, Geoffroy Coteur, Owen Davies, Bernard Combe
The Journal of Rheumatology Mar 2011, jrheum.100935; DOI: 10.3899/jrheum.100935